NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA .

Famous Munafa Ebook, free scanners! Intraday scanner, FNO scanner, High profit BTST stocks!

Outlook Therapeutics (OTLK) Technical (Analysis) Reports Outlook Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Outlook Therapeutics (OTLK)

Technical Analysis Report for NASDAQ stock OTLK Outlook Therapeutics. Dated: 29 Oct 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock OTLK Outlook Therapeutics then click here. or read Experts views on Outlook Therapeutics or Forecast & share price targets of Outlook Therapeutics

Outlook Therapeutics Opened at 0.53 and Closed at: 0.49, which is -10.2% of previous session's close. It moved within a range of 0.48 and 0.54
The session was a Bearish session with an average volume of 6899649, which is 71.26% of previous session's volumes.

Support for tomorrow is 0.46 and resistance for tomorrow is 0.52
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 0.47, 0.44 resistance for tomorrow's hourly charts is 0.53, 0.56

10 Day SMA for Outlook Therapeutics (OTLK) is 0.52 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Outlook Therapeutics (OTLK) is 0.54 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Outlook Therapeutics (OTLK) is 0.6 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 0.95 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Outlook Therapeutics is 0.67 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Outlook Therapeutics is at 0.54 and 200 DMA is at 0.67, while 50 DMA and 100 DMA are at 0.6 and 0.95 respectively

Outlook Therapeutics (OTLK) moving average of 20 SMA is at 0.54 and 20 EMA is at 0.55

Outlook Therapeutics (OTLK) moving average of 50 SMA is at 0.6 and 50 EMA is at 0.62

Outlook Therapeutics (OTLK) moving average of 100 SMA is at 0.95 and 100 EMA is at 0.75

Outlook Therapeutics (OTLK) moving average of 200 SMA is at 0.67 and 200 EMA is at 0.94

Tenax Therapeutics has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Tenax Therapeutics, about 10.89% more returns!

Supernus Pharmaceuticals has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Supernus Pharmaceuticals, about 15.68% more returns!

Outlook Therapeutics has performed better than Syndax Pharmaceuticals in short term. Holding Outlook Therapeutics could be a better choice for now!

Sellas Life has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Sellas Life, about 3.49% more returns!

Pulmatrix Inc has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Pulmatrix Inc, about 7.4% more returns!

Nektar Therapeutics has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Nektar Therapeutics, about 6.85% more returns!

Akari Therapeutics has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Akari Therapeutics, about 8.69% more returns!

Ani Pharmaceuticals has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Ani Pharmaceuticals, about 18.31% more returns!

Aquestive Therapeutics has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Aquestive Therapeutics, about 5.74% more returns!

Outlook Therapeutics has performed better than Accuray Incorporated in short term. Holding Outlook Therapeutics could be a better choice for now!

Arvinas Inc has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Arvinas Inc, about 23.56% more returns!

Assembly Biosciences has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Assembly Biosciences, about 9.5% more returns!

Incyte Corporation has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Incyte Corporation, about 18.25% more returns!

Lifevantage Corporation has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Lifevantage Corporation, about 13.66% more returns!

Livanova Plc has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Livanova Plc, about 25.18% more returns!

Outlook Therapeutics Technical analysis of indicators

Price action analysis of Outlook Therapeutics (OTLK) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.

ADX buy sell signal for Outlook Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a BUY signal for Outlook Therapeutics in short term but the buy signal is initial and weak.

Outlook Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Outlook Therapeutics in short term and SELL signal is strong!

RSI is generating a SELL signal in short term and selling is picking up momentum.

MRSI is in negative zone. This is the SELL zone

Stock of Outlook Therapeutics is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 0.52 and Outlook Therapeutics OTLK stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Outlook Therapeutics OTLK stock. Volume based technical analysis of Outlook Therapeutics OTLK stock is negative.

Outlook Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock OTLK Outlook Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And OTLK Experts View which covers a lot of information including buying and selling signals

OTLK future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Outlook Therapeutics or View Candle Stick Charts here

Share on: WhatsApp Facebook Tweet